Multaq Update: European Safety Review Expanded To Cardiovascular Side Effects Risk In July 2011
Multaq Update: European Safety Review Expanded To Cardiovascular Side Effects Risk In July 2011 EMA And FDA Already Had Sanofi Issue A 'Dear Doctor' Letter About Liver Failure In January 2011 http://www.drug-injury.com/druginjurycom/2011/07/dronedarone-sanofi-trial-heart-problems-multaq-ema-fda-safety-study-liver-injury.html
Contributor
About
I have a national litigation practice based in Wilmington, North Carolina, representing people who have cases involving prescription drug injury lawsuits and asbestos-mesothelioma claims.
I have a national litigation practice based in Wilmington, North Carolina, representing people who have cases involving prescription drug injury lawsuits and asbestos-mesothelioma claims.
Related Documents in Personal Injury
Categories
- Articles 309
- Bankruptcy 44
- Business 134
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 57
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 608
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4